NCT05228899View on ClinicalTrials.gov

Zofin to Treat COVID-19 Long Haulers

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

April 14, 2022

Primary Completion Date

October 1, 2023

Study Completion Date

October 18, 2023

Conditions
COVID-19
Interventions
DRUG

Zofin

1mL of Zofin will be administered intravenously, containing 2-5 x 10\^11 particles/mL. Zofin will be diluted in 100 mL of sterile saline.

OTHER

Placebo

1mL of Placebo (normal saline) will be diluted in 100 mL of sterile saline and administered intravenously.

Trial Locations (4)

33157

Innovation Clinical Trials, Miami

77091

United Memorial Medical Center, Houston

91606

Assuta Family Medical Group, North Hollywood

92663

NewportNativeMD, Newport Beach

All Listed Sponsors
lead

ZEO ScientifiX, Inc.

INDUSTRY